>
Trump Morphs From Asset to Liability for Israel
This Silicon Anode Breakthrough Could Mark A Turning Point For EV Batteries [Update]
US-Russia detente pushing ahead with or without Zelensky
Silver up over $2.26... Today! $71.24 (and Gold close to $4500)
Travel gadget promises to dry and iron your clothes – totally hands-free
Perfect Aircrete, Kitchen Ingredients.
Futuristic pixel-raising display lets you feel what's onscreen
Cutting-Edge Facility Generates Pure Water and Hydrogen Fuel from Seawater for Mere Pennies
This tiny dev board is packed with features for ambitious makers
Scientists Discover Gel to Regrow Tooth Enamel
Vitamin C and Dandelion Root Killing Cancer Cells -- as Former CDC Director Calls for COVID-19...
Galactic Brain: US firm plans space-based data centers, power grid to challenge China
A microbial cleanup for glyphosate just earned a patent. Here's why that matters
Japan Breaks Internet Speed Record with 5 Million Times Faster Data Transfer

The Department of Health and Human Services report, which is expected to be published this month, will raise "low folate levels and acetaminophen during pregnancy" as possible causes of autism, people familiar with the matter told the Wall Street Journal.
The review will also highlight folinic acid, known as leucovorin, as a possible therapy to ease autism symptoms in some patients, sources told the Journal.
Autism affected about one in 31 8-year-olds in the US in 2022, according to federal estimates.
Tylenol, manufactured by McNeil Consumer Healthcare, a Kenvue subsidiary, is one of the most widely used over-the-counter painkillers — including among pregnant women.
Its active ingredient, acetaminophen, has been studied for decades.
Some research has suggested risks to fetal development, but other studies found no such link.
"We are using gold-standard science to get to the bottom of America's unprecedented rise in autism rates," an HHS spokesperson told The Post Friday.
"Until we release the final report, any claims about its contents are nothing more than speculation."
The Post has sought comment from Kenvue.
Shares of Kenvue plummeted by 16% after the Journal initially published its story during the course of trading on Wall Street on Friday afternoon — though the stock recovered somewhat near the closing bell.
The American College of Obstetricians and Gynecologists continues to say Tylenol is safe for pregnant women, though it advises all expectant mothers to consult doctors before taking any medication.
Kennedy's report will review existing scientific literature, not a new clinical study, sources told the Journal.
Researchers have long cautioned that pinpointing autism's causes takes years of rigorous work, with genetic factors already proven to play a major role.
"Nothing is more important to us than the health and safety of the people who use our products," a Kenvue spokeswoman told the WSJ.
"We have continuously evaluated the science and continue to believe there is no causal link between acetaminophen use during pregnancy and autism."
The looming report could go beyond Tylenol, sources told the Journal, by listing other possible causes of autism and calling for more research.
It is not yet clear whether vaccines — the longtime target of Kennedy's skepticism — will be included.